| Raymond James Financial, Inc. | (NY: RJF) |
|
USD
|
|
Official Closing Price
/ Updated: /
|
| View: | Quote | News | Research |
(RJF) Community Analysis from
Bulls REASONS TO BUY
Bears REASONS TO SELL
June 19, 2013
(Robert Weinstein Trading Blog,
10/15/11)
Raymond James Financial, Inc. (RJF) is due to report earnings after the closing bell on October 19,...(read more)
(Wax Ink,
12/19/10)
I went with my friend Cobb last weekend to an "investor breakfast". If you have never been to one, they are usually put on by a brokerage or money management firm and are geared towards...(read more)
(Benzinga,
9/29/10)
Endo Pharmaceuticals (NASDAQ: ENDP) was upgraded by Oppenheimer from “perform” to "outperform." ENDP's shares closed at $33.10 yesterday. Endo's quarterly earnings surged 72.38% y/y.
Jefferies upgraded Callon Petroleum Company...(read more)
Raymond James Financial (RJF) Company Overview
Raymond James Financial (RJF) manages money for both wealthy individuals and assists middle-market companies in raising money. [1]
In 2004, the Private Client Group switched from a commission based model, one where the client pays per trade, to a fee based structure, one where the client pays a fee as a percentage of assets under management. As a result, recurring revenue has steadily increased from 40% of total gross revenue to 60% in 2007. This gives the company a more stable revenue stream because the company makes money even if clients do not trade.
(Read more at Wikinvest
) What's in this RJF analysis on Wikinvest...
- Business Financials
- Trends and Forces
- Tight Credit and Falling Stock Markets Hurt RJF's Investment Banking
- U.S. Economic Recession Reduce Assets Under Management
- Growth at RJBank Increases Net Interest Income and Loans
- Minimal Exposure to Subprime Loans and Buying Discounted Loans
- Competition
- References
